NLRP3 and familial dilated cardiomyopathy: Evidence has shown that excessive changes in or regulation of NLRP3 inflammasome activity can promote the immunomodulatory response in DCM mice, whereas NLRP3 gene silencing can improve diabetic cardiac remodeling and impair cardiac function (Fig. 2) [45].